anesthesia glp 1 A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general AAOMS may update anesthesia guide
Description
"As part of an extension trial published a year later, participants regained an average of two-thirds of the weight they shed within 12 months of discontinuing the drug." Within 12 months of discontinuing the drug, participants regained an average of two-thirds of the weight they shed

The short version: the Reddit consensus on Lemme is largely positive
I would recommend not spending any money on these because I dont think theyre going to do anything meaningful, she says

DATA AVAILABILITY The datasets and reagents generated during the current study are available from the corresponding author upon reasonable request

Sometimes in a good way

Heartburn and dyspepsia occur in approximately 3-9% of patients taking GLP-1 medications according to clinical trial data